{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:20:29Z","timestamp":1792376429320,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jneuroim.2008.03.008","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T02:53:57Z","timestamp":1209869637000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barr\u00e8 syndrome"],"prefix":"10.1016","volume":"196","author":[{"given":"Katia","family":"Mangano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Dati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Quattrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clorinda","family":"Mazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Bendtzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zaratin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.03.008_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(84)80193-0","article-title":"Cyclophosphamide (Cytoxan): a review on relevant pharmacology and clinical uses","volume":"11","author":"Ahmed","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/clin.1997.4331","article-title":"IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses","volume":"83","author":"Bai","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1750-3639.2002.tb00459.x","article-title":"The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis","volume":"12","author":"Bao","year":"2002","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib4","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.4049\/jimmunol.177.10.6603","article-title":"Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells","volume":"177","author":"Brode","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","article-title":"An overview of cyclophosphamide development and clinical application","volume":"5","author":"Colvin","year":"1999","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jaut.1998.0259","article-title":"Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination","volume":"12","author":"Deretzi","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/jaut.1999.0317","article-title":"Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10","volume":"13","author":"Di Marco","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-5728(99)00048-X","article-title":"Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis","volume":"97","author":"Fujioka","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2007.07.005","article-title":"High dose cyclophosphamide preferentially targets naive T (CD45\/CD4\/RA+) cells in CIDP and MS patients","volume":"190","author":"Gladstone","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/cimm.1994.1156","article-title":"Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1","volume":"156","author":"Gregorian","year":"1994","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib11","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/mus.880161106","article-title":"Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis","volume":"16","author":"Hahn","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.03.008_bib12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.03.008_bib13","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.03.008_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0404.1986.tb03287.x","article-title":"Effect of cyclophosphamide pretreatment on autoimmune encephalomyelitis in rats","volume":"73","author":"K\u00e4ll\u00e9n","year":"1986","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jneuroim.2003.10.036","article-title":"Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis","volume":"146","author":"Karni","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib16","first-page":"211","article-title":"Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course","volume":"148","author":"Kiefer","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-5728(00)00323-4","article-title":"Sequential expression of chemokines in experimental autoimmune neuritis","volume":"110","author":"Kieseier","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2006.01.004","article-title":"Immunolocalization and activation of nuclear factor-kappaB in the sciatic nerves of rats with experimental autoimmune neuritis","volume":"174","author":"Laura","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib18","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00262-007-0305-4","article-title":"Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine","volume":"56","author":"Liu","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00262-001-0237-3","article-title":"Th2\/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model","volume":"50","author":"Matar","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0960-8966(01)00302-9","article-title":"Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models","volume":"12","author":"Maurer","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneuro0452","article-title":"From bench to bedside\u2014experimental rationale for immune-specific therapies in the inflamed peripheral nerve","volume":"3","author":"Meyer zu H\u00f6rste","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2005.07.019","article-title":"Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barr\u00e8 syndrome and experimental allergic neuritis","volume":"168","author":"Nicoletti","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-4159.2006.04309.x","article-title":"Lovastatin attenuates nerve injury in an animal model of Guillain-Barr\u00e8 syndrome","volume":"100","author":"Sarkey","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib25","first-page":"519","article-title":"Long term administration of cyclophosphamide into MRL\/1 mice. II. The effects on the isotype of anti-DNA antibodies and immunoglobulin secreting cells in the spleen","volume":"55","author":"Shiraki","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1191\/1352458502ms790oa","article-title":"Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunological effects","volume":"8","author":"Weiner","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jnen\/61.7.614","article-title":"Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen","volume":"61","author":"Yu","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2007.01.015","article-title":"A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats","volume":"185","author":"Yun","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/clin.1997.4356","article-title":"Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin","volume":"84","author":"Zhu","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.1994.tb06142.x","article-title":"Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis","volume":"98","author":"Zhu","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","article-title":"Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barr\u00e8 syndrome","volume":"84","author":"Zhu","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.03.008_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1097-4547(19990415)56:2<123::AID-JNR2>3.0.CO;2-G","article-title":"IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue","volume":"56","author":"Zou","year":"1999","journal-title":"J. Neurosci. Res."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:07:59Z","timestamp":1759046879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0165572808000660"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.03.008","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barr\u00e8 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}